Carotid artery stenting protected with an emboli containment system

• Published in: Stroke (1970) 2002-05, Vol.33 (5), p.1308-1314
• Main Authors: WHITLOW, Patrick L, LYLYK, Pedro, LONDERO, Hugo, MENDIZ, Oscar A, MATHIAS, Klaus, JAEGER, Horst, PARODI, Juan, SCHÖNHOLZ, Claudio, MILEI, Jose
• Format: Article
• Language: English
• Subjects: Aged; Biological and medical sciences; Blood Vessel Prosthesis Implantation - adverse effects; Blood Vessel Prosthesis Implantation - instrumentation; Carotid Arteries - pathology; Carotid Arteries - surgery; Carotid Stenosis - pathology; Carotid Stenosis - surgery; Catheterization - instrumentation; Catheterization - methods; Female; Filtration - instrumentation; Hemorrhage - etiology; Humans; Intracranial Embolism - prevention & control; Ischemic Attack, Transient - etiology; Male; Medical sciences; Particle Size; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Stents; Technology. Biomaterials. Equipments. Material. Instrumentation; Thrombosis - pathology; Thrombosis - prevention & control; Thrombosis - surgery; Treatment Outcome
• ISSN: 0039-2499; 1524-4628
• DOI: 10.1161/01.STR.0000013947.17575.B3

Fear of distal embolization and stroke has aroused concern regarding carotid stenting. Devices to protect the cerebral circulation may make carotid stenting safer. A multidisciplinary study group tested a balloon occlusion-aspiration emboli entrapment device in conjunction with carotid stenting. The device consists of an elastomeric balloon on a steerable wire with a detachable adapter that inflates and deflates the distal temporary occlusion balloon. An aspiration catheter is used to remove trapped emboli after stenting and before occlusion balloon deflation. Seventy-five patients with severe internal carotid artery stenosis were treated with stents deployed with this cerebrovasculature protection system. All 75 patients (100%) had grossly visible particulate material aspirated, and all were treated successfully without major or minor stroke or death at 30 days. Preintervention stenosis was 81+/-10%, and residual stenosis was 5+/-7%. Nine patients (12%) had angiographic evidence of thrombus before intervention, but no patient had thrombus or vessel cutoff after the procedure. Four patients (5%) developed transient neurological symptoms during protection balloon occlusion, but symptoms resolved with balloon deflation. The 22 to 667 particles aspirated per patient ranged from 3.6 to 5262 microm in maximum diameter (mean, 203+/-256 microm). These particles included fibrous plaque debris, lipid or cholesterol vacuoles, and calcific plaque fragments. Protected carotid stenting was performed successfully and safely in this study early in the experience with cerebrovascular protection devices. Particulate emboli are frequent with stenting, and cerebral protection will likely be necessary to minimize stroke. Randomized trials comparing protected carotid stenting with endarterectomy are warranted.